Biotech companies in San Diego – List of top 25 best largest, fastest growing, entry level, startups, private, biotech companies in San Diego, USA with contact details, address and telephone numbers for good jobs
List of top 25 best biotech companies in San Diego !
JLABS @ San Diego, 3210 Merryfield Row, San Diego, CA 92121, United States. Phone: +1 858-242-1504
Johnson & Johnson Innovation – JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world.
JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow.
At JLABS, they value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. Also, JLABS also produces campaigns to seek out the best science called QuickFire Challenges.
Ajinomoto Althea, Inc., 11040 Roselle St, San Diego, CA 92121, United States. Phone: +1 858-882-0123
At Ajinomoto Bio-Pharma Services, their mission is to help improve the health of humankind. Their ultimate goal is to provide adaptive solutions, responsive service, trusted partnerships and peace of mind to customers. Through innovation, accountability, compliance, communication and teamwork, they take pride in knowing their efforts are helping countless patients for years to come.
With locations in Belgium, United States, Japan, and India, they are focused on teamwork and working in tandem to leverage their global infrastructure to provide adaptive solutions and responsive service to the biotechnology and pharmaceutical companies worldwide. They maintain an impressive and successful global regulatory track record and are vigilant in sustaining superior EH&S standards.
AvantGen, Inc, 6162 Nancy Ridge Dr #150, San Diego, CA 92121, United States. Phone: +1 858-381-5214
AvantGen is a San Diego-based biotechnology company founded in 2006 with Therapeutic and Research & Diagnostic divisions. Its Therapeutic Division is dedicated to novel human antibody discovery, antibody humanization, antibody affinity maturation and optimization for therapeutic development.
AvantGen has a proprietary and robust yeast display system, large natural human antibody database, fully human antibody (Germliner™) libraries and screening technologies and collaborates with pharmaceutical and biotechnology companies to facilitate and speed their path to antibody-based therapeutic development through services, partnerships, and licensing.
Additionally, AvantGen has developed a novel platform to generate rabbit monoclonal antibodies with very high affinity and specificity by combining AvantGen’s yeast display system and the alternate diversity obtained from the immune responses in rabbits. With this platform, AvantGen’s Research & Diagnostic Division develops high quality rabbit monoclonal antibodies for high value diagnostic targets for NIH’s proteomic projects.
Also, AvantGen provides services to pharmaceutical and biotech companies as well as academic researchers for their needs in obtaining superior rabbit monoclonal antibodies.
Neurocrine Biosciences Inc., 12780 El Camino Real, San Diego, CA 92130, United States. Phone: +1 858-617-7600
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with 28 years of experience discovering and developing life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, endometriosis* and Parkinson’s disease and clinical development programs in multiple therapeutic areas.
These areas include gene therapy for Parkinson’s disease, chorea in Huntington disease, congenital adrenal hyperplasia, epilepsy, uterine fibroids* and polycystic ovary syndrome*.
Headquartered in San Diego, Neurocrine Biosciences specializes in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. Their research group continues to advance novel small molecule compounds into clinical development, while their scientists are focusing on developing small molecule modulators of G-protein coupled receptors (GPCRs), solute carrier proteins (SLCs) and ion channels.
Batu Biologics, 9255 Towne Centre Dr #450, San Diego, CA 92121, United States. Phone: +1 760-274-7168
Batu Biologics is an immune oncology Company based out of San Diego, California. They were founded in December of 2013 to investigate the parallels between placental and tumor angiogenesis with the goal of discovering an effective natural treatment for cancer. Currently, Batu Biologics is focused on developing the “ValloVax™” platform, an allogeneic and universal donor cellular vaccine designed to stimulate a targeted immune response against several tumor angiogenesis antigens for the treatment of a wide array of cancers.
Batu Biologics believes that the maximum efficacy of treating cancer can only be achieved by targeting multiple tumor mechanisms concurrently and targeting biological pathways that have already been demonstrated to be critical for the cancer to grow. The Company has acquired intellectual property to develop parallel treatments for multiple pathways associated with tumor growth. Batu Biologics’ lead therapeutic product, ValloVax™, is a cancer vaccine targeting the tumor blood vessels – structures critical to sustainable tumor growth and progression to malignant stages.
Histogen, Inc., 10655 Sorrento Valley Rd, San Diego, CA 92121, United States. Phone: +1 858-200-9520
Histogen is a regenerative medicine company focused on developing patented, innovative technologies for aesthetic and therapeutic markets that replace and regenerate tissues in the body. The Company currently has three product candidates in clinical development intended to address what Histogen believes to be underserved, multi-billion dollar global markets: a treatment for hair loss, a dermal filler and a treatment for joint cartilage repair.
The company was founded in 2007 and is focused on developing innovative products based upon Histogen’s unique technology that utilizes the proteins and growth factors produced by cells grown under simulated embryonic conditions. The Company is headquartered in San Diego, California.
Allele Biotechnology, 6404 Nancy Ridge Dr, San Diego, CA 92121, United States. Phone: +1 800-991-7624
Established in 1999 Allele Biotechnology has focused on developing and adapting cutting edge technology for clinical and therapeutic use. Over the years Allele’s has worked on biological advancements that have been at the forefront of molecular biology research, including RNA interference, Fluorescent Proteins, Induced Pluripotent Stem Cells (iPSCs), Genome Editing, and camelid derived Single Domain Antibodies. In 2015 Allele established a cGMP facility in San Diego to further the clinical development of iPSC based cell therapy.
Over the past decade Allele Biotechnology has developed and patented (USPTO 10119150, 10155929) its proprietary iPSC reprogramming and differentiation methods that are based on non-integrating mRNA technology to enable the clinical use of iPSCs. mRNA based reprogramming allows for precise stoichiometric control of reagents and yields robust stem cells with unparalleled efficiency.
Genomatica, 4757 Nexus Center Dr, San Diego, CA 92121, United States. Phone: +1 858-824-1771
They develop commercial biobased processes to make widely-used chemicals that enable better, more sustainable everyday products. That enables their partners and leading brands to offer better food packaging, auto parts, clothing, tires, carpets, cosmetic ingredients, cleaning products and more.
They’ve commercialized processes for bio-BDO (for plastics) and for biobased butylene glycol (for cosmetics); and their technology drives the world’s first commercial-scale biobased plant for a major intermediate chemical. They’re working on polyamide intermediates (nylon), and on long-chain chemicals (cleaning products, to replace palm oil as feedstock).
Cidara Therapeutics, 6310 Nancy Ridge Dr #101, San Diego, CA 92121, United States. Phone: +1 858-752-6170
Cidara is a clinical-stage biotechnology company focused on developing new anti-infectives and immunotherapies that have the potential to transform the standard of care and save or improve patients’ lives.
The company is developing therapeutics to improve the standard of care for patients facing serious fungal or viral infections. Also, the Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak antiviral platform. Cidara is headquartered in San Diego, California.
Samumed, LLC, 9360 Towne Centre Dr, San Diego, CA 92121, United States. Phone: +1 858-926-2900
Samumed is a leader in medical research and development for tissue-level regeneration. With their platform’s origins in small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. They adopt a novel approach to the business of life sciences, combining and balancing medical priorities, fiscal efficiency, and social responsibility.
In doing so, they strive to reward investors by approaching each program with urgency. Besides, they work with the necessary partners, advisors, and clinicians to develop high-quality medical solutions in all relevant jurisdictions.
AnaptysBio, Inc, 10421 Pacific Center Ct Suite 200, San Diego, CA 92121, United States. Phone: +1 858-362-6295
AnaptysBio is a clinical-stage biotechnology company developing first-in-class immunology therapeutic product candidates to patients. They are focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. Also, they develop product candidates using proprietary antibody discovery technology platform, which is based upon a breakthrough understanding of the natural process of antibody generation, known as somatic hypermutation, or SHM, and replicates this natural process of antibody generation in vitro.
The company’s strategy is to advance the development of proprietary product candidates, and where applicable, establish partnerships with leading biopharmaceutical companies where they retain certain development and commercialization rights.
AnaptysBio’s most advanced wholly-owned antibody programs, etokimab, ANB019, ANB030 and ANB032, are designed to modulate therapeutic targets that are genetically associated with human inflammatory disorders. They are advancing etokimab, their proprietary anti-interleukin-33 antibody, for the treatment of chronic rhinosinusitis with nasal polyps and eosinophilic asthma.
Miltenyi Biotec, 6125 Cornerstone Ct E #4732, San Diego, CA 92121, United States. Phone: +1 866-811-4466
Miltenyi Biotec develops highly sophisticated tools for biomedical research and cellular therapy. They are proud of their products that help scientists, clinicians, and patients worldwide to make progress in their fight against severe diseases such as cancer. Owner-operated, the company is known for its research-driven corporate culture and a campus-like atmosphere. This promotes an interdisciplinary working environment and stimulates creativity and innovation. Biologists, chemists, physicists, engineers, clinicians, IT experts, and many other professions all work together to achieve ambitious goals.
They promote the careers of employees by offering training courses in their in-house academy or in extramural institutions. The company offers corporate benefits relating to employee health, sports and social events. At their headquarters in Bergisch Gladbach, they offer individual part-time solutions and provide an employee childcare center.
Vividion Therapeutics, 5820 Nancy Ridge Dr, San Diego, CA 92121, United States. Phone: +1 858-345-4690
Vividion Therapeutics is transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. They are advancing a broad, diversified pipeline of selective small molecule therapeutics for multiple highly sought-after disease-modifying target proteins in oncology and immunology.
Their small molecule therapeutics work through versatile mechanisms of action tailored to suit the therapeutic target, including functional inhibitors, protein degraders, and other modulators of protein function. They have an unmatched ability to understand exactly where molecules are engaging in a protein, providing a level of precision rarely seen in small molecule drug discovery, and thereby limiting the risk of unintended off-target side effects. The resulting highly selective small molecule therapeutics have the potential to achieve a broad impact on human health across the globe.
Tocagen, 4242 Campus Point Ct #500, San Diego, CA 92121, United States. Phone: +1 858-412-8400
Driven by their vision, as a fully integrated global biotech company, their mission is to develop first-in-class, broadly applicable, product candidates that are designed to activate a patient’s immune system against their own cancer from within. They believe that even the most aggressive forms of cancer can be safely and effectively controlled, and each day they strive to turn their bold vision into reality.
At the core of their approach is a cancer-selective gene therapy platform that utilizes retroviral replicating vectors (RRVs), which are designed to deliver therapeutic genes into the DNA of cancer cells. RRV-mediated gene delivery fights cancer through a combination of mechanisms without the autoimmune toxicities that patients commonly experience with other treatments. In other words, their technology is intended to combat cancer with fewer side effects, keeping patients’ healthy tissue intact while the tumor is destroyed.
ACEA Biosciences, 6779 Mesa Ridge Rd # 100, San Diego, CA 92121, United States. Phone: +1 858-724-0928
Founded in 2002, ACEA Biosciences, Inc. is a privately owned biotechnology company that is pioneering the development and commercialization of high performance, cutting edge cell analysis instruments for life science research and clinical diagnostics. Employing noninvasive impedance microelectrodes in automated high-throughput plate formats, their xCELLigence® Real-Time Cell Analysis (RTCA) instruments maximize the physiological relevance of data extracted from in vitro cellular assays.
These instruments enable label-free, real-time monitoring of cell proliferation, cell size/morphology, cell-substrate attachment quality, and cell invasion/migration. By eliminating the time- and labor-intensive steps of traditional methods, RTCA vastly improves efficiency and overall productivity. Moreover, the flexibility, sensitivity, and reproducibility of RTCA make it a standout amongst cell-based assay platforms.
ACEA is also helping to revolutionize the field of flow cytometry by designing and producing high performance, customizable benchtop cytometers at accessible price points. By including features such as 13 fluorescence detection channels with 3 lasers, direct volumetric based cell counting, and a versatile high throughput walkaway autosampler, ACEA’s line of NovoCyte® flow cytometers is raising the bar for what is expected of benchtop machines.
HUYA Bioscience International, 12531 High Bluff Dr # 138, San Diego, CA 92130, United States. Phone: +1 858-798-8800
HUYA Bioscience International® is the leader in accelerating the global development of novel biopharmaceutical product opportunities originating in China enabling faster, more cost-effective and lower-risk drug development global markets. Through extensive collaboration with biopharmaceutical, academic and commercial organizations, it has built the largest Chinasourced compound portfolio covering all therapeutic areas.
With offices in the US, Japan, South Korea, Canada, Ireland and eight strategic locations across China, the Company has become a partner of choice to accelerate product development and maximize value globally.
The other companies that complete this list of top 25 best biotech companies in San Diego includes the following:
Epitope Diagnostics, Inc., 7110 Carroll Rd, San Diego, CA 92121, United States. Phone: +1 858-693-7877
CTK Biotech, 13855 Stowe Dr, Poway, CA 92064, United States. Phone: +1 858-457-8698
Otonomy Inc, 4796 Executive Dr, San Diego, CA 92121, United States. Phone: +1 619-323-2200
Inova Diagnostics, Inc., 9900 Old Grove Rd, San Diego, CA 92131, United States. Phone: +1 858-586-9900
GenWay Biotech Inc, 7700 Ronson Rd, San Diego, CA 92111, United States. Phone: +1 858-458-0866
iXCells Biotechnologies, 10340 Camino Santa Fe Suite C, San Diego, CA 92121, United States. Phone: +1 858-412-5988
Biotechnical Services Inc, 9373 Activity Rd, San Diego, CA 92126, United States. Phone: +1 858-271-8961
Organovo Holdings Inc, 6275 Nancy Ridge Dr, San Diego, CA 92121, United States. Phone: +1 858-224-1000
Cibus US LLC, 6455 Nancy Ridge Dr, San Diego, CA 92121, United States. Phone: +1 858-450-0008
ALSO REFER
Pharmaceutical companies in New York City
Pharmaceutical companies in Ireland
Pharmaceutical companies in Germany
Pharmaceutical companies in USA
Pharmaceutical companies in Singapore
Pharmaceutical companies in Australia
Pharmaceutical companies in Canada
Pharmaceutical companies in UK